Salt modulates vascular response through adenosine A2A receptor in eNOS-null mice: Role of CYP450 epoxygenase and soluble epoxide hydrolase

Molecular and Cellular Biochemistry

Volumn 350, Issue 1-2, 2011, Pages 101-111

  Nayeem, Mohammed A ^a   Zeldin, Darryl C ^b   Boegehold, Matthew A ^a   Falck, John R ^c  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Adenosine; CYP2J2; eNOS; Relaxation; Salt; sEH

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ACETYLCHOLINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPOXIDE HYDROLASE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; AORTA; ARTICLE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; MOUSE; NONHUMAN;

ACETYLCHOLINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ALKANE 1-MONOOXYGENASE; ANIMALS; AORTA; BLOOD VESSELS; ENZYME INHIBITORS; EPOXIDE HYDROLASES; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; RECEPTOR, ADENOSINE A2A; SODIUM CHLORIDE, DIETARY; VASODILATOR AGENTS;

MUS;

EID: 79953727529     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0686-0     Document Type: Article

References (48)

1. Wong WT, Wong SL, Tian XY, Huang Y (2010) Endothelial dysfunction: the common consequence in diabetes and hypertension. J Cardiovasc Pharmacol 55:300-307
2. Brandes RP, Schmitz-Winnenthal FH, Feletou M, Godecke A, Huang PL, Vanhoutte PM, Fleming I, Busse R (2000) An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci USA 97:9747-9752 (Pubitemid 30650847)
3. Nayeem MA, Ponnoth DS, Boegehold MA, Zeldin DC, Falck JR, Mustafa SJ (2009) High-salt diet enhances mouse aortic relaxation through adenosine A2A receptor via CYP epoxygenases. Am J Physiol Regul Integr Comp Physiol 296:R567-R574
4. Nayeem MA, Poloyac SM, Falck JR, Zeldin DC, Ledent C, Ponnoth DS, Ansari HR, Mustafa SJ (2008) Role of CYP epoxygenases in A2A AR-mediated relaxation using A2A AR-null and wild-type mice. Am J Physiol Heart Circ Physiol 295:H2068-H2078
5. Nayeem MA, Zeldin DC, Boegehold MA, Morisseau C, Marowsky A, Ponnoth DS, Roush KP, Falck JR (2010) Modulation by salt intake of the vascular response mediated through adenosine A2A receptor: role of CYP epoxygenase and soluble epoxide hydrolase. Am J Physiol Regul Integr Comp Physiol 299(1):R325-R333
6. Elhusseiny A, Hamel E (2000) Muscarinic - but not nicotinic - acetylcholine receptors mediate a nitric oxide-dependent dilation in brain cortical arterioles: a possible role for the M5 receptor subtype. J Cereb Blood Flow Metab 20:298-305 (Pubitemid 30108448)
7. Rosenblum WI, Nishimura H, Nelson GH (1990) Endothelium-dependent L-Arg- and L-NMMA-sensitive mechanisms regulate tone of brain microvessels. Am J Physiol 259:H1396-H1401 (Pubitemid 20385738)
8. Sobey CG, Faraci FM (1997) Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles. Stroke 28:837-842 discussion 842-833
9. Faraci FM, Heistad DD (1998) Regulation of the cerebral circulation: role of endothelium and potassium channels. Physiol Rev 78:53-97 (Pubitemid 28070975)
10. Faraci FM, Sobey CG (1999) Role of soluble guanylate cyclase in dilator responses of the cerebral microcirculation. Brain Res 821:368-373 (Pubitemid 29222800)
11. Huang PL (2000) Mouse models of nitric oxide synthase deficiency. J Am Soc Nephrol 11(Suppl 16):S120-S123
12. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O (1996) Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 93:13176-13181 (Pubitemid 26382789)
13. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC (1995) Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239-242
14. Godecke A, Decking UK, Ding Z, Hirchenhain J, Bidmon HJ, Godecke S, Schrader J (1998) Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res 82:186-194 (Pubitemid 28080101)
15. Fagan KA, McMurtry I, Rodman DM (2000) Nitric oxide synthase in pulmonary hypertension: lessons from knockout mice. Physiol Res 49:539-548
16. Fagan KA, Fouty BW, Tyler RC, Morris KG Jr, Hepler LK, Sato K, LeCras TD, Abman SH, Weinberger HD, Huang PL, McMurtry IF, Rodman DM (1999) The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J Clin Invest 103:291-299 (Pubitemid 29053147)
17. Steudel W, Scherrer-Crosbie M, Bloch KD, Weimann J, Huang PL, Jones RC, Picard MH, Zapol WM (1998) Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest 101:2468-2477 (Pubitemid 28270441)
18. Chataigneau T, Feletou M, Huang PL, Fishman MC, Duhault J, Vanhoutte PM (1999) Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol 126:219-226 (Pubitemid 29041761)
19. Ding Z, Godecke A, Schrader J (2002) Contribution of cytochrome P450 metabolites to bradykinin-induced vasodilation in endothelial NO synthase deficient mouse hearts. Br J Pharmacol 135:631-638 (Pubitemid 34177640)
20. Capdevila JH, Wei S, Yan J, Karara A, Jacobson HR, Falck JR, Guengerich FP, DuBois RN (1992) Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J Biol Chem 267:21720-21726
21. Makita K, Takahashi K, Karara A, Jacobson HR, Falck JR, Capdevila JH (1994) Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J Clin Invest 94:2414-2420 (Pubitemid 24379616)
22. Hao CM, Breyer MD (2007) Physiologic and pathophysiologic roles of lipid mediators in the kidney. Kidney Int 71:1105-1115
23. Zhao X, Pollock DM, Inscho EW, Zeldin DC, Imig JD (2003) Decreased renal cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin salt-sensitive hypertension. Hypertension 41:709-714 (Pubitemid 36314579)
24. Dyke CK, Proctor DN, Dietz NM, Joyner MJ (1995) Role of nitric oxide in exercise hyperaemia during prolonged rhythmic handgripping in humans. J Physiol 488(Pt 1):259-265
25. Duffy SJ, New G, Tran BT, Harper RW, Meredith IT (1999) Relative contribution of vasodilator prostanoids and NO to metabolic vasodilation in the human forearm. Am J Physiol 276:H663-H670 (Pubitemid 29100636)
26. Hirai T, Visneski MD, Kearns KJ, Zelis R, Musch TI (1994) Effects of NO synthase inhibition on the muscular blood flow response to treadmill exercise in rats. J Appl Physiol 77:1288-1293 (Pubitemid 24299382)
27. Shoemaker JK, Halliwill JR, Hughson RL, Joyner MJ (1997) Contributions of acetylcholine and nitric oxide to forearm blood flow at exercise onset and recovery. Am J Physiol 273:H2388-H2395
28. Radegran G, Saltin B (1999) Nitric oxide in the regulation of vasomotor tone in human skeletal muscle. Am J Physiol 276:H1951-H1960 (Pubitemid 29323479)
29. Persson MG, Gustafsson LE, Wiklund NP, Hedqvist P, Moncada S (1990) Endogenous nitric oxide as a modulator of rabbit skeletal muscle microcirculation in vivo. Br J Pharmacol 100:463-466 (Pubitemid 20222275)
30. Yamada M, Ishikawa T, Fujimori A, Goto K (1997) Local neurogenic regulation of rat hindlimb circulation: role of calcitonin gene-related peptide in vasodilatation after skeletal muscle contraction. Br J Pharmacol 122:703-709 (Pubitemid 27453096)
31. Ray CJ, Marshall JM (2009) Nitric oxide (NO) does not contribute to the generation or action of adenosine during exercise hyperaemia in rat hindlimb. J Physiol 587:1579-1591
32. McGiff JC, Carroll MA (1991) Cytochrome P450-dependent arachidonate metabolites, renal function and blood pressure regulation. Adv Prostaglandin Thromboxane Leukot Res 21B:675-682
33. Bauersachs J, Hecker M, Busse R (1994) Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol 113:1548-1553 (Pubitemid 24364446)
34. Campbell WB, Gebremedhin D, Pratt PF, Harder DR (1996) Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 78:415-423 (Pubitemid 26072547)
35. Fisslthaler B, Popp R, Kiss L, Potente M, Harder DR, Fleming I, Busse R (1999) Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 401:493-497 (Pubitemid 29470209)
36. Gebremedhin D, Harder DR, Pratt PF, Campbell WB (1998) Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: role of a cytochrome P450 metabolite. J Vasc Res 35:274-284 (Pubitemid 28368309)
37. + channels. Circ Res 83:501-507
38. Mombouli JV, Vanhoutte PM (1997) Endothelium-derived hyperpolarizing factor(s): updating the unknown. Trends Pharmacol Sci 18:252-256
39. Oltman CL, Weintraub NL, VanRollins M, Dellsperger KC (1998) Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ Res 83:932-939 (Pubitemid 28503082)
40. Popp R, Bauersachs J, Hecker M, Fleming I, Busse R (1996) A transferable, beta-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells. J Physiol 497(Pt 3):699-709 (Pubitemid 27032908)
41. Quilley J, McGiff JC (2000) Is EDHF an epoxyeicosatrienoic acid? Trends Pharmacol Sci 21:121-124
42. Fang X, Kaduce TL, Weintraub NL, Harmon S, Teesch LM, Morisseau C, Thompson DA, Hammock BD, Spector AA (2001) Pathways of epoxyeicosatrienoic acid metabolism in endothelial cells. Implications for the vascular effects of soluble epoxide hydrolase inhibition. J Biol Chem 276:14867-14874
43. Bauersachs J, Popp R, Hecker M, Sauer E, Fleming I, Busse R (1996) Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation 94:3341-3347 (Pubitemid 26427507)
44. Nishikawa Y, Stepp DW, Chilian WM (2000) Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo. Am J Physiol Heart Circ Physiol 279:H459-H465
45. Cheng MK, Doumad AB, Jiang H, Falck JR, McGiff JC, Carroll MA (2004) Epoxyeicosatrienoic acids mediate adenosine-induced vasodilation in rat preglomerular microvessels (PGMV) via A2A receptors. Br J Pharmacol 141:441-448 (Pubitemid 38297007)
46. Node K, Ruan XL, Dai J, Yang SX, Graham L, Zeldin DC, Liao JK (2001) Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem 276:15983-15989
47. Popp R, Brandes RP, Ott G, Busse R, Fleming I (2002) Dynamic modulation of interendothelial gap junctional communication by 11,12-epoxyeicosatrienoic acid. Circ Res 90:800-806 (Pubitemid 34633896)
48. Li PL, Chen CL, Bortell R, Campbell WB (1999) 11,12-Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle. Circ Res 85:349-356 (Pubitemid 29398867)